Evolution of the Average Target: IRADIMED CORPORATION

Evolution of the Target Price: IRADIMED CORPORATION

Changes in Analyst Recommendations: IRADIMED CORPORATION

2e.4d4iFZQHuI2j0c2vi-jHOH5vyPOJ3QOvok7pVtBeoBc.1bV2crky4b3hnvnCuIOjXjwpobHeglf37X2xOZUp2X6WmGdN4T7h3pKknA~52743e7f0a8e41d9f402cc29193c7297

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +28.72%
+50.67%
+23.63%
+83.01%
- - +57.23%
Average +48.65%
Weighted average by Cap. +45.54%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
91.67USD
Average target price
118.00USD
Spread / Average Target
+28.72%
High Price Target
120.00USD
Spread / Highest target
+30.90%
Low Price Target
116.00USD
Spread / Lowest Target
+26.54%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Roth Capital Partners
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
91.67USD
Average target price
118.00USD
Spread / Average Target
+28.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock
  4. Consensus IRADIMED CORPORATION